Cost-consequence analysis of penile prosthesis implantation in outpatient setting in Spain

Autor: Josep Torremadé, María Presa, Óscar Gorría, Esperanza Torres, Itziar Oyagüez, Enrique Lledó

Publikováno v: International Journal of Healthcare Management. :1-8

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e280ed5584512a3ed8d37e40fd9115ef
https://doi.org/10.1080/20479700.2022.2163336

Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in Spain

Autor: Vicente Estrada, Miguel Górgolas, José A. Peña, Elena Tortajada, Antonio Castro, María Presa, Itziar Oyagüez

Publikováno v: PharmacoEconomics - Open. 6:415-424

This study aimed to assess the potential epidemiological and economic impact of rapid initiation of human immunodeficiency virus (HIV) treatment with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) on HIV transmission compared with the curr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274a8569fe0612b06f817b5159849bfd
https://doi.org/10.1007/s41669-022-00322-w

Targeted screening for human immunodeficiency virus infection in Spanish emergency departments: an analysis of epidemiologic and economic impact

Autor: José, Moltó, Juan, González Del Castillo, Carmen, Navarro, Antonio, Castro, María, Presa, Itziar, Oyagüez

Publikováno v: Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias. 34(1)

To evaluate the potential epidemiologic and economic impact of applying an HIV screening protocol in hospital emergency departments (ED) and compare it to current clinical practice in Spain.We estimated the cumulative incidence of human immunodeficie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6454f72785a74a44ffa6bb1676779b46
https://pubmed.ncbi.nlm.nih.gov/35103440

Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain

Autor: J. Bruno Montoro, Laia Alsina, Pedro Moral Moral, Silvia Sánchez-Ramón, Miguel A. Casado, Olaf Neth, María Presa, Marta Ortiz Pica, Itziar Oyagüez, Luis Ignacio Gonzalez-Granado

Publikováno v: E-Prints Complutense. Archivo Institucional de la UCM
instname
EUROPEAN JOURNAL OF HEALTH ECONOMICS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

Primary immunodeficiency diseases (PID), which are comprised of over 400 genetic disorders, occur when a component of the immune system is diminished or dysfunctional. Patients with PID who require immunoglobulin (IG) replacement therapy receive intr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24803f9eeeba53bd269ddbabe2aacb92
https://link.springer.com/content/pdf/10.1007/s10198-021-01378-x.pdf

Second-line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients

Autor: María Presa, Itziar Oyagüez, Fernando Perez-Ruiz

Publikováno v: Clinical rheumatology. 38(12)

Lesinurad, in combination with allopurinol, has been approved for treatment of patients with gout which do not reach therapeutic serum urate target with xanthine oxidase inhibitors monotherapy. The study aimed to assess the incremental cost-effective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::295fc63842e4ab08f0e6cf1ff503759d
https://pubmed.ncbi.nlm.nih.gov/31420811